--- title: "IRIDEX CORP (IRIX) stock listing, news and investor profile" url: "https://aibio.space/companies/iridex/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "IRIDEX CORP (NASDAQ: IRIX), United States. Listing facts, related biotech companies and news on aibio.space." --- IRIX IRIDEX CORP NASDAQ · United States # IRIDEX CORP (IRIX) news IRIDEX CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IRIX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest IRIDEX CORP news We have not published a story on IRIDEX CORP yet. When there is news, it will appear here. ## IRIDEX CORP at a glance - **Ticker**: IRIX - **Listing**: NASDAQ - **Country**: United States - **Cash, Jul 4, 2026**: $4.7 million ### Related companies - [Bausch & Lomb](https://aibio.space/companies/bausch-lomb/) NYSE: BLCO - [Burning Rock Biotech](https://aibio.space/companies/burning-rock-biotech/) NASDAQ: BNR - [MiniMed Group](https://aibio.space/companies/minimed/) NASDAQ: MMED - [Electromed](https://aibio.space/companies/electromed/) NYSE: ELMD - [REPLIGEN CORP](https://aibio.space/companies/repligen/) NASDAQ: RGEN - [VYCOR MEDICAL INC](https://aibio.space/companies/vycor-medical/) OTC: VYCO - [SANUWAVE Health](https://aibio.space/companies/sanuwave-health/) NASDAQ: SNWV - [KORU Medical Systems](https://aibio.space/companies/koru-medical-systems/) NASDAQ: KRMD ### Also on NASDAQ - [TANDEM DIABETES CARE INC](https://aibio.space/companies/tandem-diabetes-care/) TNDM - [Inovio Pharmaceuticals](https://aibio.space/companies/inovio-pharmaceuticals/) INO - [Nautilus Biotechnology](https://aibio.space/companies/nautilus-biotechnology/) NAUT - [Longeveron](https://aibio.space/companies/longeveron/) LGVN - [Prime Medicine](https://aibio.space/companies/prime-medicine/) PRME - [Gyre Therapeutics](https://aibio.space/companies/gyre-therapeutics/) GYRE ## IRIDEX CORP annual financials | Line | FY ended Jan 3, 2026 | FY ended Dec 28, 2024 | |---|---|---| | Research and development | [$3.7 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | [$5.4 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | | Net income (loss) | [-$4.4 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | [-$8.9 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | | Cash from operations | [-$2.1 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | [-$7.3 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | | Cash and equivalents | [$6.0 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526355641/) | [$2.4 million](https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/) | Latest balance sheet, Jul 4, 2026 (10-Q): cash and equivalents $4.7 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about IRIDEX CORP What is the ticker symbol of IRIDEX CORP? IRIDEX CORP trades under the ticker IRIX on NASDAQ. Where is IRIDEX CORP listed? IRIDEX CORP is listed on NASDAQ. Which country or territory is IRIDEX CORP listed under? Our directory records IRIDEX CORP under United States. Does aibio.space cover IRIDEX CORP? aibio.space lists IRIDEX CORP among 2,820 public biotech companies and publishes its news here as stories appear. Is IRIDEX CORP profitable? IRIDEX CORP reported a net loss of $4.4 million for the fiscal year ended Jan 3, 2026, and used $2.1 million of cash in operations, per its annual report to the SEC. How much does IRIDEX CORP spend on research and development? $3.7 million in the fiscal year ended Jan 3, 2026, per its annual report. How much cash does IRIDEX CORP have? $4.7 million in cash at Jul 4, 2026, per its 10-Q. ## Investor discussion: IRIDEX CORP Members talk about IRIDEX CORP (IRIX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at IRIDEX CORP, newest first. Each line links the filing it comes from. 1. 2026-09-02 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1006045/000119312526380229/irix-20260827.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IRIX on TradingView](https://www.tradingview.com/symbols/NASDAQ-IRIX/). ## Listing details IRIDEX CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IRIX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: IRIDEX CORP - **Ticker**: IRIX - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/iridex/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "IRIDEX CORP (IRIX) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/iridex/